HIV controllers can control viral replication and remain healthy, but the mechanism behind this control is unknown. Despite human leukocyte antigen (HLA) diversity in the population, almost 50% of HIV controllers express the HLA-B∗57:01 molecule, which presents, among others, the Gag-derived epitope TW10. Given TW10’s presentation in early infection, TW10-specific T cells could participate in the control of HIV. Here, we study the strength and functionality of TW10-specific T cells from HLA-B∗57:01+/HIV+ controller and non-controller individuals. We determine the TW10-specific T cell receptor (TCR) repertoire, revealing a bias in TCR gene usage with the presence of a public TCR. We determine that the T cell response is polyfunctional regardless of the viral load, despite the low affinity of TW10-specific TCRs. We solve the crystal structure of HLA-B∗57:01-TW10 in complex with a TCR, providing the basis of recognition that underpins the strong TRBV5 bias observed in TW10-specific clonotypes.
Funding
The authors would like to thank Monash University (Macromolecular Crystallisation Facility, Imaging Facility) and the Burnet Institute Facilities, in particular Dr. Magdaline Costa and the AMREPFlow Core Manager Geza Paukovics (PC3 AMREP Flow Cytometry) , PathWest Laboratory Medicine for HLA typing, and the MX team for assistance at the Australian Synchrotron. This research was undertaken in part using the MX2 beamline at the Australian Synchrotron, part of ANSTO, and made use of the ACRF detector. The authors would also like to thank all the participants who took part in our study. This work was supported by financial contributions from National Health and Medical Research Council (NHMRC) ideas grant awarded to L.J.D'O. and S.G. (#2021082) , Monash and La Trobe Universities, and the Australian Nuclear Science and Technology Organisation (ANSTO, AINSE ECR grants) . D.S.M.C. is supported by an AINSE ECR grant form ANSTO, and S.G. is supported by NHMRC SRF (#1159272) .